NCT06268821 - Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated With Basal Insulin in Finland | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

July 12, 2024

Study Completion Date

July 12, 2024

Conditions

Type 2 Diabetes Treated With Insulin

Interventions

DEVICE

FreeStyle Libre 2 Flash Glucose Monitoring System

Glucose sensors to be worn continuously for 3 months with data used to monitor and manage diabetes treatment and to inform lifestyle choices (diet and exercise)

Trial Locations (2)

33100

Pihlajalinna Koskiklinikka, Hatanpäänvaltatie 1,, Tampere

42100

Pihlajalinna Jämsä, Välikatu 1,, Jämsä